Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025)

Amylyx Pharmaceuticals' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q3 2025.

• On a quarterly basis, Asset Utilization Ratio fell 100.34% year-over-year to 0.0 in Q3 2025; TTM through Sep 2025 was 0.0, a 100.34% decrease from a year earlier, with the FY2024 full-year figure at 0.25, down 70.66% from the prior year.
• Asset Utilization Ratio fell to 0.0 in Q3 2025 per AMLX's latest filing, from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.85 in Q1 2024 and bottomed at 0.0 in Q3 2025.
• The 4-year median for Asset Utilization Ratio is 0.42 (2023), against an average of 0.41.
• Across the five-year window, Asset Utilization Ratio soared 884.63% in 2023 and plunged 100.34% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.08 in 2022, then surged by 884.63% to 0.77 in 2023, then plunged by 47.98% to 0.4 in 2024, then sank by 100.57% to 0.0 in 2025.
• Per Business Quant, the three latest AMLX Asset Utilization Ratio figures stand at 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025).